Corrigendum to: Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatment [Surgery. 2020 Jan;167(1):189-196. doi: 10.1016/j.surg.2019.05.092. Epub 2019 Oct 16.PMID: 31629542] (Surgery (2020) 167(1) (189–196), (S0039606019305835), (10.1016/j.surg.2019.05.092))

Academic Article


  • The authors regret not including the full funding support for this publication. The Funding/Support paragraph should be corrected as follows: Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (NCATS NIH) under award number UL1TR001417 and by American Cancer Society under the award number ACS-IRG -18-162-59-IRG. The content is the sole responsibility of the authors and does not represent the official views of the National Institutes of Health. The authors would like to apologise for any inconvenience caused.
  • Published In

  • Surgery  Journal
  • Digital Object Identifier (doi)

    Author List

  • Guenter R; Aweda T; Carmona Matos DM; Jang S; Whitt J; Cheng YQ; Liu XM; Chen H; Lapi SE; Jaskula-Sztul R
  • Start Page

  • 351
  • Volume

  • 170
  • Issue

  • 1